Unveiling lactylation: A novel frontier in the pathogenesis of diabetic nephropathy (Review)

Li MJ, Liu HY, Zhang YQ, Li SR, Zhang JH and Li R: Global burden of chronic kidney disease and its attributable risk factors (1990-2021): An analysis based on the global burden of disease study. Front Endocrinol (Lausanne). 16:15632462025. View Article : Google Scholar : PubMed/NCBI

de Sa JR, Rangel EB, Canani LH, Bauer AC, Escott GM, Zelmanovitz T, Bertoluci MC and Silveiro SP: The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: An evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD. Diabetol Metab Syndr. 14:812022. View Article : Google Scholar : PubMed/NCBI

Sanghavi SF, Roark T, Zelnick LR, Najafian B, Andeen NK, Alpers CE, Pichler R, Ayers E and de Boer IH: Histopathologic and clinical features in patients with diabetes and kidney disease. Kidney360. 1:1217–1225. 2020. View Article : Google Scholar : PubMed/NCBI

Barutta F, Bellini S and Gruden G: Mechanisms of podocyte injury and implications for diabetic nephropathy. Clin Sci (Lond). 136:493–520. 2022. View Article : Google Scholar : PubMed/NCBI

Wang M, Huang Z, Li X, He P, Sun H, Peng Y and Fan Q: Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis. Pharmacol Res. 207:1073062024. View Article : Google Scholar : PubMed/NCBI

Chen Q, Xie C, Tang K, Luo M, Zhang Z, Jin Y, Liu Y, Zhou L and Kong Y: The E3 ligase Trim63 promotes podocyte injury and proteinuria by targeting PPARalpha to inhibit fatty acid oxidation. Free Radic Biol Med. 209:40–54. 2023. View Article : Google Scholar : PubMed/NCBI

Song S, Hu T, Shi X, Jin Y, Liu S, Li X, Zou W and Wang C: ER Stress-perturbed intracellular protein O-GlcNAcylation aggravates podocyte injury in diabetes nephropathy. Int J Mol Sci. 24:176032023. View Article : Google Scholar : PubMed/NCBI

He M, Wang Z, Miao Z, Zhao Y, Wei L, Zhang L, Yin R, Wang Y and Yang L: Post-translational modifications in diabetic kidney disease (Review). Int J Mol Med. 57:882026. View Article : Google Scholar

Gu W, Wang X, Zhao H, Geng J, Li X, Zheng K, Guan Y, Hou X, Wang C and Song G: Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway. Eur J Pharmacol. 918:1747762022. View Article : Google Scholar : PubMed/NCBI

Qi B, Chen Y, Chai S, Lu X and Kang L: O-linked beta-N-acetylglucosamine (O-GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy. Diabet Med. 42:e154362025. View Article : Google Scholar

Zhu W, Guo S, Sun J, Zhao Y and Liu C: Lactate and lactylation in cardiovascular diseases: current progress and future perspectives. Metabolism. 158:1559572024. View Article : Google Scholar : PubMed/NCBI

Xu B, Liu Y, Li N and Geng Q: Lactate and lactylation in macrophage metabolic reprogramming: Current progress and outstanding issues. Front Immunol. 15:13957862024. View Article : Google Scholar : PubMed/NCBI

Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, Zou Y, Wang JX, Wang Z and Yu T: Lactate metabolism in human health and disease. Signal Transduct Target Ther. 7:3052022. View Article : Google Scholar : PubMed/NCBI

Warburg O, Wind F and Negelein E: The metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927. View Article : Google Scholar : PubMed/NCBI

Dimitriadis GD, Maratou E, Kountouri A, Board M and Lambadiari V: Regulation of postabsorptive and post-prandial glucose metabolism by Insulin-Dependent and Insulin-independent mechanisms: An Integrative Approach. Nutrients. 13:1592021. View Article : Google Scholar

Lee DY, Kim JY, Ahn E, Hyeon JS, Kim GH, Park KJ, Jung Y, Lee YJ, Son MK, Kim SW, et al: Associations between local acidosis induced by renal LDHA and renal fibrosis and mitochondrial abnormalities in patients with diabetic kidney disease. Transl Res. 249:88–109. 2022. View Article : Google Scholar : PubMed/NCBI

Darshi M, Kugathasan L, Maity S, Sridhar VS, Fernandez R, Limonte CP, Grajeda BI, Saliba A, Zhang G, Drel VR, et al: Glycolytic lactate in diabetic kidney disease. JCI Insight. 9:e1688252024. View Article : Google Scholar : PubMed/NCBI

Azushima K, Kovalik JP, Yamaji T, Ching J, Chng TW, Guo J, Liu JJ, Nguyen M, Sakban RB, George SE, et al: Abnormal lactate metabolism is linked to albuminuria and kidney injury in diabetic nephropathy. Kidney Int. 104:1135–1149. 2023. View Article : Google Scholar : PubMed/NCBI

Kugathasan L, Darshi M, Srinivasan Sridhar V, Drel V, Tumova J, Liu JJ, Wang J, Perkins BA, Lytvyn Y, Natarajan L, et al: 12-OR: Urine lactate is a disease biomarker for diabetic kidney disease. Diabetes. 72:12–OR. 2023. View Article : Google Scholar

Chen Y, Liu X, Shengbu M, Shi Q, Jiaqiu S and Lai X: Biomarkers: New advances in diabetic nephropathy. Natural Product Communications. 20:1934578X2513217582025. View Article : Google Scholar

Xu Y, Li X, Mao Z and Xue C: Protein lactylation in kidney diseases. Front Cell Dev Biol. 13:15331752025. View Article : Google Scholar : PubMed/NCBI

Cheng Y and Guo L: Lactate metabolism and lactylation in kidney diseases: Insights into mechanisms and therapeutic opportunities. Ren Fail. 47:24697462025. View Article : Google Scholar : PubMed/NCBI

Zhou M, Liu L, Sun Y and Wang X: Lactylation in diabetes mellitus and its complications: Mechanisms of action and therapeutic potential-recent advances. Front Endocrinol (Lausanne). 16:17106452025. View Article : Google Scholar

Wei X, Long M, Yu J and Du Y: The lactate-lactylation axis in renal fibrosis: Potential mechanisms in diabetic kidney disease. Ann Med. 57:25873262025. View Article : Google Scholar : PubMed/NCBI

Gao M, Wang M, Zhou S, Hou J, He W, Shu Y and Wang X: Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma. Cancer Cell Int. 24:4002024. View Article : Google Scholar : PubMed/NCBI

Fu C, Jia Z, Fu Y, Zhang Y, Wu Y, Cao X, Cao D and Jiang J: The clinical prognostic value of lactylation-regulated proteins in gastric cancer. J Proteome Res. 25:446–459. 2026. View Article : Google Scholar :

Yang X, Li G, Jiang R, Yang Y, Zhu H, Huang L, Li T, Zhou J and Liu Z: Lactylation-related gene signatures for prognosis and treatment response prediction in radiation-resistant non-small cell lung cancer. Discover Oncol. 16:17872025. View Article : Google Scholar

Wu Q, Qiu X and Chen H: Advancements in early biomarkers of acute kidney injury: From traditional indicators to a paradigm shift in lactate metabolism. Ann Med. 58:26123832026. View Article : Google Scholar : PubMed/NCBI

Concepción M, Quiroz J, Suarez J, Paz J, Roseboom P, Ildefonso S, Cribilleros D, Zavaleta F, Coronado J and Concepción L: Novel Biomarkers for the diagnosis of diabetic nephropathy. Caspian J Intern Med. 15:382–391. 2024.PubMed/NCBI

Cai D, Yuan X, Cai DQ, Li A, Yang S, Yang W, Duan J, Zhuo W, Min J, Peng L and Wei J: Integrative analysis of lactylation-related genes and establishment of a novel prognostic signature for hepatocellular carcinoma. J Cancer Res Clin Oncol. 149:11517–11530. 2023. View Article : Google Scholar : PubMed/NCBI

Kemp E, Jacobsen IA and Amtrup F: LDH release into perfusates of preserved kidneys. Scand J Urol Nephrol. 10:142–146. 1976. View Article : Google Scholar : PubMed/NCBI

Valvona CJ, Fillmore HL, Nunn PB and Pilkington GJ: The regulation and function of lactate dehydrogenase a: Therapeutic potential in brain tumor. Brain Pathol. 26:3–17. 2016. View Article : Google Scholar

Osis G, Traylor AM, Black LM, Spangler D, George JF, Zarjou A, Verlander JW and Agarwal A: Expression of lactate dehydrogenase A and B isoforms in the mouse kidney. Am J Physiol Renal Physiol. 320:F706–F718. 2021. View Article : Google Scholar : PubMed/NCBI

Brooks GA: Cell-cell and intracellular lactate shuttles. J Physiol. 587:5591–5600. 2009. View Article : Google Scholar : PubMed/NCBI

Becker HM, Klier M and Deitmer JW: Nonenzymatic augmentation of lactate transport via monocarboxylate transporter isoform 4 by carbonic anhydrase II. J Membr Biol. 234:125–135. 2010. View Article : Google Scholar : PubMed/NCBI

Iwanaga T and Kishimoto A: Cellular distributions of monocarboxylate transporters: A review. Biomed Res. 36:279–301. 2015. View Article : Google Scholar : PubMed/NCBI

Halestrap AP: Monocarboxylic acid transport. Compr Physiol. 3:1611–1643. 2013. View Article : Google Scholar : PubMed/NCBI

Becker HM, Mohebbi N, Perna A, Ganapathy V, Capasso G and Wagner CA: Localization of members of MCT monocarboxylate transporter family Slc16 in the kidney and regulation during metabolic acidosis. Am J Physiol Renal Physiol. 299:F141–F154. 2010. View Article : Google Scholar : PubMed/NCBI

Thangaraju M, Ananth S, Martin PM, Roon P, Smith SB, Sterneck E, Prasad PD and Ganapathy V: c/ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney. J Biol Chem. 281:26769–26773. 2006. View Article : Google Scholar : PubMed/NCBI

Py G, Lambert K, Perez-Martin A, Raynaud E, Prefaut C and Mercier J: Impaired sarcolemmal vesicle lactate uptake and skeletal muscle MCT1 and MCT4 expression in obese Zucker rats. Am J Physiol Endocrinol Metab. 281:E1308–F1315. 2001. View Article : Google Scholar : PubMed/NCBI

Py G, Lambert K, Milhavet O, Eydoux N, Prefaut C and Mercier J: Effects of streptozotocin-induced diabetes on markers of skeletal muscle metabolism and monocarboxylate transporter 1 to monocarboxylate transporter 4 transporters. Metabolism. 51:807–813. 2002. View Article : Google Scholar : PubMed/NCBI

Enoki T, Yoshida Y, Hatta H and Bonen A: Exercise training alleviates MCT1 and MCT4 reductions in heart and skeletal muscles of STZ-induced diabetic rats. J Appl Physiol (1985). 94:2433–2438. 2003. View Article : Google Scholar : PubMed/NCBI

Ahmed K, Tunaru S and Offermanns S: GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends Pharmacol Sci. 30:557–562. 2009. View Article : Google Scholar : PubMed/NCBI

Hoque R, Farooq A, Ghani A, Gorelick F and Mehal WZ: Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity. Gastroenterology. 146:1763–1774. 2014. View Article : Google Scholar : PubMed/NCBI

Jones NK, Stewart K, Czopek A, Menzies RI, Thomson A, Moran CM, Cairns C, Conway BR, Denby L, Livingstone DEW, et al: Endothelin-1 mediates the systemic and renal hemodynamic effects of GPR81 activation. Hypertension. 75:1213–1222. 2020. View Article : Google Scholar : PubMed/NCBI

Brown TP and Ganapathy V: Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon. Pharmacol Ther. 206:1074512020. View Article : Google Scholar

Yang K, Xu J, Fan M, Tu F, Wang X, Ha T, Williams DL and Li C: Lactate suppresses macrophage pro-inflammatory response to LPS stimulation by inhibition of YAP and NF-κB Activation via GPR81-mediated signaling. Front Immunol. 11:5879132020. View Article : Google Scholar

Ranganathan P, Shanmugam A, Swafford D, Suryawanshi A, Bhattacharjee P, Hussein MS, Koni PA, Prasad PD, Kurago ZB, Thangaraju M, et al: GPR81, a Cell-surface receptor for lactate, regulates intestinal homeostasis and protects mice from experimental colitis. J Immunol. 200:1781–1789. 2018. View Article : Google Scholar : PubMed/NCBI

Llibre A, Kucuk S, Gope A, Certo M and Mauro C: Lactate: A key regulator of the immune response. Immunity. 58:535–554. 2025. View Article : Google Scholar : PubMed/NCBI

Guo S, Ye M, Zhu W and Liu C: From fuel to epigenetic signal: Lactate-lactylation axis orchestrates diabetic complications. Pharmacol Res. 222:1080522025. View Article : Google Scholar : PubMed/NCBI

Liu J, Zhao F and Qu Y: Lactylation: A novel post-translational modification with clinical implications in CNS diseases. Biomolecules. 14:11752024. View Article : Google Scholar : PubMed/NCBI

Ishihara S, Hata K, Hirose K, Okui T, Toyosawa S, Uzawa N, Nishimura R and Yoneda T: The lactate sensor GPR81 regulates glycolysis and tumor growth of breast cancer. Sci Rep. 12:62612022. View Article : Google Scholar : PubMed/NCBI

Chen S, Zhou L, Sun J, Qu Y and Chen M: The role of cAMP-PKA pathway in Lactate-induced intramuscular triglyceride accumulation and mitochondria content increase in mice. Front Physiol. 12:7091352021. View Article : Google Scholar : PubMed/NCBI

Wang H, Yang M, Liu X, Fan J and Wang C: G protein-coupled receptor-mediated renal fibrosis: A key focus on kidney disease drug development. Front Pharmacol. 16:16458882025. View Article : Google Scholar : PubMed/NCBI

Zhi Y, Fan K, Liu S, Hu K, Zan X, Lin L, Yang Y, Gong X, Chen K, Tang L, et al: Deletion of GPR81 activates CREB/Smad7 pathway and alleviates liver fibrosis in mice. Mol Med. 30:992024. View Article : Google Scholar : PubMed/NCBI

Wu X, Xu M, Geng M, Chen S, Little PJ, Xu S and Weng J: Targeting protein modifications in metabolic diseases: Molecular mechanisms and targeted therapies. Signal Transduct Target Ther. 8:2202023. View Article : Google Scholar : PubMed/NCBI

Liu Y, Guo X, Hu X, Zhou S, Yang Q, Feng P and Zeng L: Lysine lactylation in diseases: Beyond histone lactylation. Cell Death Dis. 17:552025. View Article : Google Scholar : PubMed/NCBI

Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, et al: Metabolic regulation of gene expression by histone lactylation. Nature. 574:575–580. 2019. View Article : Google Scholar : PubMed/NCBI

Moreno-Yruela C, Zhang D, Wei W, Bæk M, Liu W, Gao J, Danková D, Nielsen AL, Bolding JE, Yang L, et al: Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 8:eabi66962022. View Article : Google Scholar : PubMed/NCBI

Cui H, Xie N, Banerjee S, Ge J, Jiang D, Dey T, Matthews QL, Liu RM and Liu G: Lung myofibroblasts promote macrophage profibrotic activity through lactate-induced histone lactylation. Am J Respir Cell Mol Biol. 64:115–125. 2021. View Article : Google Scholar

Xie B, Zhang M, Li J, Cui J, Zhang P, Liu F, Wu Y, Deng W, Ma J, Li X, et al: KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proc Natl Acad Sci USA. 121:e23141281212024. View Article : Google Scholar : PubMed/NCBI

Wang N, Wang W, Wang X, Mang G, Chen J, Yan X, Tong Z, Yang Q, Wang M, Chen L, et al: Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ Res. 131:893–908. 2022. View Article : Google Scholar : PubMed/NCBI

Dong H, Zhang J, Zhang H, Han Y, Lu C, Chen C, Tan X, Wang S, Bai X, Zhai G, et al: YiaC and CobB regulate lysine lactylation in Escherichia coli. Nat Commun. 13:66282022. View Article : Google Scholar : PubMed/NCBI

Wang J, Wang Z, Wang Q, Li X and Guo Y: Ubiquitous protein lactylation in health and diseases. Cell Mol Biol Lett. 29:232024. View Article : Google Scholar : PubMed/NCBI

Zong Z, Ren J, Yang B, Zhang L and Zhou F: Emerging roles of lysine lactyltransferases and lactylation. Nat Cell Biol. 27:563–574. 2025. View Article : Google Scholar : PubMed/NCBI

Gaffney DO, Jennings EQ, Anderson CC, Marentette JO, Shi T, Schou Oxvig AM, Streeter MD, Johannsen M, Spiegel DA, Chapman E, et al: Non-enzymatic Lysine lactoylation of glycolytic enzymes. Cell Chem Biol. 27:206–213.e6. 2020. View Article : Google Scholar

Chen X, Yuan Y, Zhou F, Li L, Pu J, Zeng Y and Jiang X: Lactylation: From homeostasis to pathological implications and therapeutic strategies. MedComm (2020). 6:e702262025. View Article : Google Scholar : PubMed/NCBI

Zheng T, Gu YP, Wang JM, Huang TT, Gou LS and Liu YW: Lactate-triggered histone lactylation contributes to podocyte epithelial-mesenchymal transition in diabetic nephropathy in mice. Chem Biol Interact. 408:1114182025. View Article : Google Scholar : PubMed/NCBI

Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, Huang H, Lu H, Song H, Yang B, et al: AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature. 634:1229–1237. 2024. View Article : Google Scholar : PubMed/NCBI

Che X, Zhang Y, Chen X, Xie G, Li J, Xu C, Zhang C, Zhu Y and Yang X: The lactylation-macrophage interplay: Implications for gastrointestinal disease therapeutics. Front Immunol. 16:16081152025. View Article : Google Scholar : PubMed/NCBI

Wan L, Zhang H, Liu J, He Q, Zhao J, Pan C, Zheng K and Tang Y: Lactylation and human disease. Expert Rev Mol Med. 27:e102025. View Article : Google Scholar : PubMed/NCBI

Lu Z, Zheng X, Shi M, Yin Y, Liang Y, Zou Z, Ding C, He Y, Zhou Y and Li X: Lactylation: The emerging frontier in post-translational modification. Front Genet. 15:14232132024. View Article : Google Scholar : PubMed/NCBI

Wang T, Ye Z, Li Z, Jing DS, Fan GX, Liu MQ, Zhuo QF, Ji SR, Yu XJ, Xu XW and Qin Y: Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer. Cell Prolif. 56:e134782023. View Article : Google Scholar : PubMed/NCBI

Zhao L, Qi H, Lv H, Liu W, Zhang R and Yang A: Lactylation in health and disease: Physiological or pathological? Theranostics. 15:1787–1821. 2025. View Article : Google Scholar : PubMed/NCBI

Chen J, Feng Q, Qiao Y, Pan S, Liang L, Liu Y, Zhang X, Liu D and Liu Z and Liu Z: ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes. Diabetologia. 67:1429–1443. 2024. View Article : Google Scholar : PubMed/NCBI

Hong J, Xu H, Yu L, Yu Z, Chen X, Meng Z, Zhu J, Li J and Zhu M: AARS1-mediated lactylation of H3K18 and STAT1 promotes ferroptosis in diabetic nephropathy. Cell Death Differ. Sep 23–2025. View Article : Google Scholar : Epub ahead of print. PubMed/NCBI

Zhang X, Chen J, Lin R, Huang Y, Wang Z, Xu S, Wang L, Chen F, Zhang J, Pan K and Yin Z: Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la/KLF5 pathway. Redox Biol. 75:1032462024. View Article : Google Scholar : PubMed/NCBI

Qian J, Huang C, Wang M, Liu Y, Zhao Y, Li M, Zhang X, Gao X, Zhang Y, Wang Y, et al: Nuclear translocation of metabolic enzyme PKM2 participates in high glucose-promoted HCC metastasis by strengthening immunosuppressive environment. Redox Biol. 71:1031032024. View Article : Google Scholar : PubMed/NCBI

Song M, Liu B, Wang H and Sun W: Lactate metabolism and lactylation modification: New opportunities and challenges in cardiovascular disease. MedComm (2020). 6:e702692025. View Article : Google Scholar : PubMed/NCBI

Peng X and Du J: Histone and non-histone lactylation: Molecular mechanisms, biological functions, diseases, and therapeutic targets. Mol Biomed. 6:382025. View Article : Google Scholar : PubMed/NCBI

Tessarz P and Kouzarides T: Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol. 15:703–708. 2014. View Article : Google Scholar : PubMed/NCBI

Dai W, Wu G, Liu K, Chen Q, Tao J, Liu H and Shen M: Lactate promotes myogenesis via activating H3K9 lactylation-dependent up-regulation of Neu2 expression. J Cachexia Sarcopenia Muscle. 14:2851–2865. 2023. View Article : Google Scholar : PubMed/NCBI

Sun T, Zhang JN, Lan T, Shi L, Hu L, Yan L, Wei C, Hei L, Wu W, Luo Z, et al: H3K14 lactylation exacerbates neuronal ferroptosis by inhibiting calcium efflux following intracerebral hemorrhagic stroke. Cell Death Dis. 16:5532025. View Article : Google Scholar : PubMed/NCBI

Zhang J, Yang Y, Chen X, Chen H, Kuang E, Deng M and Wang F: Histone lactylation dynamics are associated with impaired maternal-to-zygotic transition in vitro-cultured goat embryos. Theriogenology. 256:1178592026. View Article : Google Scholar : PubMed/NCBI

Jiang Z, Xiong N, Yan R, Li ST, Liu H, Mao Q, Sun Y, Shen S, Ye L, Gao P, et al: PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation-mediated gene expression. Protein Cell. 16:49–63. 2025. View Article : Google Scholar :

Yang Y, Wen J, Lou S, Han Y, Pan Y, Zhong Y, He Q, Zhang Y, Mo X, Ma J and Shen N: DNAJC12 downregulation induces neuroblastoma progression via increased histone H4K5 lactylation. J Mol Cell Biol. 16:mjae0562025. View Article : Google Scholar :

Guan B, Zhou M, Dai W, Zhang J, Xie B, Mi Y, Zhang X, Wei P, Liu Y, Li S, et al: Peritumoral colonic epithelial cell-derived GDF15 sustains colorectal cancer via regulation of glycolysis and histone lactylation. Nat Aging. 5:2449–2465. 2025. View Article : Google Scholar : PubMed/NCBI

Yang Y, Song L, Yu L, Zhang J and Zhang B: H4K12 lactylation potentiates mitochondrial oxidative stress via the Foxo1 pathway in diabetes-induced cognitive impairment. J Adv Res. 78:391–407. 2025. View Article : Google Scholar : PubMed/NCBI

Jiao Q, Ren Y, Teng X, Feng M, Liu X, Cai Y, Hu T, Wang M and Wang Y: Positive feedback between histone H4K16 lactylation and glycolysis promotes MAFLD progression. Hepatol Int. Dec 2–2025. View Article : Google Scholar : Epub ahead of print. PubMed/NCBI

Galle E, Wong CW, Ghosh A, Desgeorges T, Melrose K, Hinte LC, Castellano-Castillo D, Engl M, de Sousa JA, Ruiz-Ojeda FJ, et al: H3K18 lactylation marks tissue-specific active enhancers. Genome Biol. 23:2072022. View Article : Google Scholar : PubMed/NCBI

Pan L, Feng F, Wu J, Fan S, Han J, Wang S, Yang L, Liu W, Wang C and Xu K: Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacol Res. 181:1062702022. View Article : Google Scholar : PubMed/NCBI

Pan RY, He L, Zhang J, Liu X, Liao Y, Gao J, Liao Y, Yan Y, Li Q, Zhou X, et al: Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer's disease. Cell Metab. 34:634–648.e6. 2022. View Article : Google Scholar : PubMed/NCBI

Chen J, He J, Wang X, Bai L, Yang X, Chen J, He Y and Chen K: Glis1 inhibits RTEC cellular senescence and renal fibrosis by downregulating histone lactylation in DKD. Life Sci. 361:1232932025. View Article : Google Scholar

Gao M, Zhang N and Liang W: Systematic analysis of lysine lactylation in the plant fungal pathogen botrytis cinerea. Front Microbiol. 11:5947432020. View Article : Google Scholar : PubMed/NCBI

Zhao W, Yu H, Liu X, Wang T, Yao Y, Zhou Q, Zheng X and Tan F: Systematic identification of the lysine lactylation in the protozoan parasite Toxoplasma gondii. Parasit Vectors. 15:1802022. View Article : Google Scholar : PubMed/NCBI

Dong H, Sun Y, Nie L, Cui A, Zhao P, Leung WK and Wang Q: Metabolic memory: Mechanisms and diseases. Signal Transduct Target Ther. 9:382024. View Article : Google Scholar : PubMed/NCBI

Erekat NS: Programmed cell death in diabetic nephropathy: A review of apoptosis, autophagy, and necroptosis. Med Sci Monit. 28:e9377662022. View Article : Google Scholar : PubMed/NCBI

Yu H, Zhu T, Ma D, Cheng X, Wang S and Yao Y: The role of nonhistone lactylation in disease. Heliyon. 10:e362962024. View Article : Google Scholar : PubMed/NCBI

Tang S, Sun Y, Sun W, Kang X, Zhao X, Jiang L, Gao Q, An X, Ji H and Lian F: Programmed cell death in diabetic kidney disease: Mechanisms and therapeutic targeting. J Inflamm Res. 18:13001–13037. 2025. View Article : Google Scholar : PubMed/NCBI

Watkins PA, Maiguel D, Jia Z and Pevsner J: Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. J Lipid Res. 48:2736–2750. 2007. View Article : Google Scholar : PubMed/NCBI

Perera RJ, Marcusson EG, Koo S, Kang X, Kim Y, White N and Dean NM: Identification of novel PPARgamma target genes in primary human adipocytes. Gene. 369:90–99. 2006. View Article : Google Scholar

Wiese EK, Hitosugi S, Loa ST, Sreedhar A, Andres-Beck LG, Kurmi K, Pang YP, Karnitz LM, Gonsalves WI and Hitosugi T: Enzymatic activation of pyruvate kinase increases cytosolic oxaloacetate to inhibit the Warburg effect. Nat Metab. 3:954–968. 2021. View Article : Google Scholar : PubMed/NCBI

Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MAR, Sheedy FJ, Gleeson LE, van den Bosch MWM, Quinn SR, Domingo-Fernandez R, Johnston DGW, et al: Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 21:3472015. View Article : Google Scholar

Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, Aldape K, Hunter T, Alfred Yung WK and Lu Z: PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell. 150:685–696. 2012. View Article : Google Scholar : PubMed/NCBI

Ouyang X, Han SN, Zhang JY, Dioletis E, Nemeth BT, Pacher P, Feng D, Bataller R, Cabezas J, Stärkel P, et al: Digoxin suppresses pyruvate kinase M2-promoted HIF-1α transactivation in steatohepatitis. Cell Metab. 27:11562018. View Article : Google Scholar

Kocak MZ, Aktas G, Atak BM, Duman TT, Yis OM, Erkus E and Savli H: Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Invest. 50:e132062020. View Article : Google Scholar : PubMed/NCBI

Amdur RL, Feldman HI, Gupta J, Yang W, Kanetsky P, Shlipak M, Rahman M, Lash JP, Townsend RR, Ojo A, et al: Inflammation and progression of CKD: The CRIC study. Clin J Am Soc Nephrol. 11:1546–1556. 2016. View Article : Google Scholar : PubMed/NCBI

Qi W, Keenan HA, Li Q, Ishikado A, Kannt A, Sadowski T, Yorek MA, Wu IH, Lockhart S, Coppey LJ, et al: Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat Med. 23:753–762. 2017. View Article : Google Scholar : PubMed/NCBI

Li L, Tang L, Yang X, Chen R, Zhang Z, Leng Y and Chen AF: Gene regulatory effect of pyruvate kinase M2 is involved in renal inflammation in type 2 diabetic nephropathy. Exp Clin Endocrinol Diabetes. 128:599–606. 2020. View Article : Google Scholar : PubMed/NCBI

Gordin D, Shah H, Shinjo T, St-Louis R, Qi W, Park K, Paniagua SM, Pober DM, Wu IH, Bahnam V, et al: Characterization of glycolytic enzymes and pyruvate kinase M2 in type 1 and 2 diabetic nephropathy. Diabetes Care. 42:1263–1273. 2019. View Article : Google Scholar : PubMed/NCBI

Liu H, Takagaki Y, Kumagai A, Kanasaki K and Koya D: The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1alpha accumulation. J Diabetes Investig. 12:697–709. 2021. View Article : Google Scholar :

Zhang Z, Deng X, Liu Y, Liu Y, Sun L and Chen F: Correction to: PKM2, function and expression and regulation. Cell Biosci. 9:592019. View Article : Google Scholar : PubMed/NCBI

Angiari S, Runtsch MC, Sutton CE, Palsson-McDermott EM, Kelly B, Rana N, Kane H, Papadopoulou G, Pearce EL, Mills KHG, et al: Pharmacological activation of pyruvate kinase M2 inhibits CD4⁺ T cell pathogenicity and suppresses autoimmunity. Cell Metab. 31:391–405.e8. 2020. View Article : Google Scholar

Sweetwyne MT, Gruenwald A, Niranjan T, Nishinakamura R, Strobl LJ and Susztak K: Notch1 and Notch2 in podocytes play differential roles during diabetic nephropathy development. Diabetes. 64:4099–4111. 2015. View Article : Google Scholar : PubMed/NCBI

Yokoyama M, Tanuma N, Shibuya R, Shiroki T, Abue M, Yamamoto K, Miura K, Yamaguchi K, Sato I, Tamai K and Satoh K: Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species. Int J Oncol. 52:881–891. 2018.PubMed/NCBI

Zheng S, Liu Q, Liu T and Lu X: Posttranslational modification of pyruvate kinase type M2 (PKM2): Novel regulation of its biological roles to be further discovered. J Physiol Biochem. 77:355–363. 2021. View Article : Google Scholar : PubMed/NCBI

Prakasam G, Iqbal MA, Bamezai RNK and Mazurek S: Posttranslational modifications of pyruvate kinase M2: Tweaks that benefit cancer. Front Oncol. 8:222018. View Article : Google Scholar : PubMed/NCBI

Coassolo S, Davidson G, Negroni L, Gambi G, Daujat S, Romier C and Davidson I: Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation. Nat Commun. 12:17182021. View Article : Google Scholar : PubMed/NCBI

Xia L, Jiang Y, Zhang XH, Wang XR, Wei R, Qin K and Lu Y: SUMOylation disassembles the tetrameric pyruvate kinase M2 to block myeloid differentiation of leukemia cells. Cell Death Dis. 12:1012021. View Article : Google Scholar : PubMed/NCBI

Das Gupta K, Shakespear MR, Curson JEB, Murthy AMV, Iyer A, Hodson MP, Ramnath D, Tillu VA, von Pein JB, Reid RC, et al: Class IIa histone deacetylases drive Toll-like receptor-inducible glycolysis and macrophage inflammatory responses via pyruvate kinase M2. Cell Rep. 30:2712–2728.e8. 2020. View Article : Google Scholar : PubMed/NCBI

Singh JP, Qian K, Lee JS, Zhou J, Han X, Zhang B, Ong Q, Ni W, Jiang M, Ruan HB, et al: O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth. Oncogene. 39:560–573. 2020. View Article : Google Scholar :

Wang J, Yang P, Yu T, Gao M, Liu D, Zhang J, Lu C, Chen X, Zhang X and Liu Y: Lactylation of PKM2 suppresses inflammatory metabolic adaptation in Pro-inflammatory macrophages. Int J Biol Sci. 18:6210–6225. 2022. View Article : Google Scholar : PubMed/NCBI

Sosa RA, Terry AQ, Kaldas FM, Jin YP, Rossetti M, Ito T, Li F, Ahn RS, Naini BV, Groysberg VM, et al: Disulfide High-mobility group box 1 drives ischemia-reperfusion injury in human liver transplantation. Hepatology. 73:1158–1175. 2021. View Article : Google Scholar

Chen R, Kang R and Tang D: The mechanism of HMGB1 secretion and release. Exp Mol Med. 54:91–102. 2022. View Article : Google Scholar : PubMed/NCBI

Yang H, Zeng Q, Silverman HA, Gunasekaran M, George SJ, Devarajan A, Addorisio ME, Li J, Tsaava T, Shah V, et al: HMGB1 released from nociceptors mediates inflammation. Proc Natl Acad Sci USA. 118:e21020341182021. View Article : Google Scholar : PubMed/NCBI

Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, Liu J, Antonelli A, Preti A, Raeli L, et al: Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med. 209:1519–1528. 2012. View Article : Google Scholar : PubMed/NCBI

Tang D, Kang R, Livesey KM, Kroemer G, Billiar TR, Van Houten B, Zeh HJ III and Lotze MT: High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab. 13:701–711. 2011. View Article : Google Scholar : PubMed/NCBI

Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, et al: High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol. 290:C917–C924. 2006. View Article : Google Scholar

Kim J, Sohn E, Kim CS, Jo K and Kim JS: The role of high-mobility group box-1 protein in the development of diabetic nephropathy. Am J Nephrol. 33:524–529. 2011. View Article : Google Scholar : PubMed/NCBI

Jin J, Gong J, Zhao L, Zhang H, He Q and Jiang X: Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux. J Diabetes. 11:826–836. 2019. View Article : Google Scholar : PubMed/NCBI

Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, Chan KW, Lai KN and Tang SC: Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol. 23:86–102. 2012. View Article : Google Scholar

Zhang H, Zhang R, Chen J, Shi M, Li W and Zhang X: High mobility group box1 inhibitor glycyrrhizic acid attenuates kidney injury in streptozotocin-induced diabetic rats. Kidney Blood Press Res. 42:894–904. 2017. View Article : Google Scholar : PubMed/NCBI

Kang R, Livesey KM, Zeh HJ III, Lotze MT and Tang D: HMGB1 as an autophagy sensor in oxidative stress. Autophagy. 7:904–906. 2011. View Article : Google Scholar : PubMed/NCBI

Ling H, Chen H, Wei M, Meng X, Yu Y and Xie K: The effect of autophagy on inflammation cytokines in renal ischemia/reperfusion injury. Inflammation. 39:347–356. 2016. View Article : Google Scholar

Zhao ZB, Marschner JA, Iwakura T, Li C, Motrapu M, Kuang M, Popper B, Linkermann A, Klocke J, Enghard P, et al: Tubular epithelial cell HMGB1 promotes AKI-CKD transition by sensitizing cycling tubular cells to oxidative stress: A rationale for targeting HMGB1 during AKI recovery. J Am Soc Nephrol. 34:394–411. 2023. View Article : Google Scholar : PubMed/NCBI

Tesch G, Sourris KC, Summers SA, McCarthy D, Ward MS, Borg DJ, Gallo LA, Fotheringham AK, Pettit AR, Yap FY, et al: Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes. Diabetologia. 57:1977–1985. 2014. View Article : Google Scholar : PubMed/NCBI

Liu Y, Lu T, Zhang C, Xu J, Xue Z, Busuttil RW, Xu N, Xia Q, Kupiec-Weglinski JW and Ji H: Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. J Hepatol. 71:719–730. 2019. View Article : Google Scholar : PubMed/NCBI

Yang K, Fan M, Wang X, Xu J, Wang Y, Tu F, Gill PS, Ha T, Liu L, Williams DL and Li C: Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ. 29:133–146. 2022. View Article : Google Scholar :

Du S, Zhang X, Jia Y, Peng P, Kong Q, Jiang S, Li Y, Li C, Ding Z and Liu L: Hepatocyte HSPA12A inhibits macrophage chemotaxis and activation to attenuate liver ischemia/reperfusion injury via suppressing glycolysis-mediated HMGB1 lactylation and secretion of hepatocytes. Theranostics. 13:3856–3871. 2023. View Article : Google Scholar : PubMed/NCBI

Wu K, Zha H, Wu T, Liu H, Peng R, Lin Z, Lv D, Liao X, Sun Y and Zhang Z: Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFκB signaling pathway. Cell Mol Life Sci. 81:4082024. View Article : Google Scholar

Zhu L, Zheng Q, Liu X, Ding H, Ma M, Bao J, Cai Y and Cao C: HMGB1 lactylation drives neutrophil extracellular trap formation in lactate-induced acute kidney injury. Front Immunol. 15:14755432024. View Article : Google Scholar

Lee JS, See RH, Galvin KM, Wang J and Shi Y: Functional interactions between YY1 and adenovirus E1A. Nucleic Acids Res. 23:925–931. 1995. View Article : Google Scholar : PubMed/NCBI

Shi Y, Seto E, Chang LS and Shenk T: Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 67:377–388. 1991. View Article : Google Scholar : PubMed/NCBI

Yang T, Shu F, Yang H, Heng C, Zhou Y, Chen Y, Qian X, Du L, Zhu X, Lu Q and Yin X: YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis. Metabolism. 96:33–45. 2019. View Article : Google Scholar : PubMed/NCBI

Jha JC, Banal C, Okabe J, Gray SP, Hettige T, Chow BSM, Thallas-Bonke V, De Vos L, Holterman CE, Coughlan MT, et al: NADPH oxidase Nox5 accelerates renal injury in diabetic nephropathy. Diabetes. 66:2691–2703. 2017. View Article : Google Scholar : PubMed/NCBI

Gordon S, Akopyan G, Garban H and Bonavida B: Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology. Oncogene. 25:1125–1142. 2006. View Article : Google Scholar

Deng Z, Wan M, Cao P, Rao A, Cramer SD and Sui G: Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene. 28:3746–3757. 2009. View Article : Google Scholar : PubMed/NCBI

Gao P, Li L, Yang L, Gui D, Zhang J, Han J, Wang J, Wang N, Lu J, Chen S, et al: Yin Yang 1 protein ameliorates diabetic nephropathy pathology through transcriptional repression of TGFbeta1. Sci Transl Med. 11:eaaw20502019. View Article : Google Scholar

Wei SY, Shih YT, Wu HY, Wang WL, Lee PL, Lee CI, Lin CY, Chen YJ, Chien S and Chiu JJ: Endothelial Yin Yang 1 phosphorylation at S118 induces atherosclerosis under flow. Circ Res. 129:1158–1174. 2021. View Article : Google Scholar : PubMed/NCBI

Du L, Qian X, Li Y, Li XZ, He LL, Xu L, Liu YQ, Li CC, Ma P, Shu FL, et al: Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy. Acta Pharmacol Sin. 42:242–251. 2021. View Article : Google Scholar

Huang J, Wang X, Li N, Fan W, Li X, Zhou Q, Liu J, Li W, Zhang Z, Liu X, et al: YY1 lactylation aggravates autoimmune uveitis by enhancing microglial functions via inflammatory genes. Adv Sci (Weinh). 11:e23080312024. View Article : Google Scholar : PubMed/NCBI

Wang X, Fan W, Li N, Ma Y, Yao M, Wang G, He S, Li W, Tan J, Lu Q and Hou S: YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2. Genome Biol. 24:872023. View Article : Google Scholar : PubMed/NCBI

Yoshino J, Monkawa T, Tsuji M, Inukai M, Itoh H and Hayashi M: Snail1 is involved in the renal epithelial-mesenchymal transition. Biochem Biophys Res Commun. 362:63–68. 2007. View Article : Google Scholar : PubMed/NCBI

Katoh M and Katoh M: Comparative genomics on SNAI1, SNAI2, and SNAI3 orthologs. Oncol Rep. 14:1083–1086. 2005. View Article : Google Scholar : PubMed/NCBI

Kaufhold S and Bonavida B: Central role of Snail1 in the regulation of EMT and resistance in cancer: A target for therapeutic intervention. J Exp Clin Cancer Res. 33:622014. View Article : Google Scholar : PubMed/NCBI

Barrallo-Gimeno A and Nieto MA: The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development. 132:3151–3161. 2005. View Article : Google Scholar : PubMed/NCBI

Grande MT, Sanchez-Laorden B, Lopez-Blau C, De Frutos CA, Boutet A, Arévalo M, Rowe RG, Weiss SJ, López-Novoa JM and Nieto MA: Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med. 21:989–997. 2015. View Article : Google Scholar : PubMed/NCBI

Li SS, Sun Q, Hua MR, Suo P, Chen JR, Yu XY and Zhao YY: Targeting the Wnt/β-catenin signaling pathway as a potential therapeutic strategy in renal tubulointerstitial fibrosis. Front Pharmacol. 12:7198802021. View Article : Google Scholar

Zhao Y, Yin Z, Li H, Fan J, Yang S, Chen C and Wang DW: MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice. Aging Cell. 16:387–400. 2017. View Article : Google Scholar : PubMed/NCBI

Sala L, Franco-Valls H, Stanisavljevic J, Curto J, Vergés J, Peña R, Duch P, Alcaraz J, García de Herreros A and Baulida J: Abrogation of myofibroblast activities in metastasis and fibrosis by methyltransferase inhibition. Int J Cancer. 145:3064–3077. 2019. View Article : Google Scholar : PubMed/NCBI

Zhao X, He X, Wei W and Huang K: USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1. Eur J Pharmacol. 947:1756712023. View Article : Google Scholar : PubMed/NCBI

Fan M, Yang K, Wang X, Chen L, Gill PS, Ha T, Liu L, Lewis NH, Williams DL and Li C: Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. Sci Adv. 9:eadc94652023. View Article : Google Scholar : PubMed/NCBI

Mao RW, He SP, Lan JG and Zhu WZ: Honokiol ameliorates cisplatin-induced acute kidney injury via inhibition of mitochondrial fission. Br J Pharmacol. 179:3886–3904. 2022. View Article : Google Scholar : PubMed/NCBI

Kleele T, Rey T, Winter J, Zaganelli S, Mahecic D, Perreten Lambert H, Ruberto FP, Nemir M, Wai T, Pedrazzini T and Manley S: Distinct fission signatures predict mitochondrial degradation or biogenesis. Nature. 593:435–439. 2021. View Article : Google Scholar : PubMed/NCBI

Haileselassie B, Mukherjee R, Joshi AU, Napier BA, Massis LM, Ostberg NP, Queliconi BB, Monack D, Bernstein D and Mochly-Rosen D: Drp1/Fis1 interaction mediates mitochondrial dysfunction in septic cardiomyopathy. J Mol Cell Cardiol. 130:160–169. 2019. View Article : Google Scholar : PubMed/NCBI

Zhan M, Usman IM, Sun L and Kanwar YS: Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. J Am Soc Nephrol. 26:1304–1321. 2015. View Article : Google Scholar

Huang Q, Chen H, Yin K, Shen Y, Lin K, Guo X, Zhang X, Wang N, Xin W, Xu Y and Gui D: Formononetin attenuates renal tubular injury and mitochondrial damage in diabetic nephropathy partly via regulating Sirt1/PGC-1α pathway. Front Pharmacol. 13:9012342022. View Article : Google Scholar

Su J, Gao C, Xie L, Fan Y, Shen Y, Huang Q, Wang N, Xu Y, Yang N and Gui D: Astragaloside II ameliorated podocyte injury and mitochondrial dysfunction in streptozotocin-induced diabetic rats. Front Pharmacol. 12:6384222021. View Article : Google Scholar : PubMed/NCBI

Wang S, Zhu H, Li R, Mui D, Toan S, Chang X and Zhou H: DNA-PKcs interacts with and phosphorylates Fis1 to induce mitochondrial fragmentation in tubular cells during acute kidney injury. Sci Signal. 15:eabh11212022. View Article : Google Scholar : PubMed/NCBI

Bragoszewski P, Turek M and Chacinska A: Control of mitochondrial biogenesis and function by the ubiquitin-proteasome system. Open Biol. 7:1700072017. View Article : Google Scholar : PubMed/NCBI

Wang L, Zhang T, Wang L, Cai Y, Zhong X, He X, Hu L, Tian S, Wu M, Hui L, et al: Fatty acid synthesis is critical for stem cell pluripotency via promoting mitochondrial fission. EMBO J. 36:1330–1347. 2017. View Article : Google Scholar : PubMed/NCBI

An S, Yao Y, Hu H, Wu J, Li J, Li L, Wu J, Sun M, Deng Z, Zhang Y, et al: PDHA1 hyperacetylation-mediated lactate over-production promotes sepsis-induced acute kidney injury via Fis1 lactylation. Cell Death Dis. 14:4572023. View Article : Google Scholar

Roberts RE and Hallett MB: Neutrophil cell shape change: Mechanism and signalling during cell spreading and phagocytosis. Int J Mol Sci. 20:13832019. View Article : Google Scholar : PubMed/NCBI

Wehbi VL and Tasken K: Molecular mechanisms for cAMP-mediated immunoregulation in T cells-role of anchored protein kinase A signaling units. Front Immunol. 7:2222016. View Article : Google Scholar

Garcia-Ortiz A and Serrador JM: ERM proteins at the crossroad of leukocyte polarization, migration and intercellular Adhesion. Int J Mol Sci. 21:15022020. View Article : Google Scholar : PubMed/NCBI

Zhang X, Li G, Guo Y, Song Y, Chen L, Ruan Q, Wang Y, Sun L, Hu Y, Zhou J, et al: Regulation of ezrin tension by S-nitrosylation mediates non-small cell lung cancer invasion and metastasis. Theranostics. 9:2555–2571. 2019. View Article : Google Scholar : PubMed/NCBI

McRobert EA and Bach LA: Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products. Nephrology (Carlton). 21:13–20. 2016. View Article : Google Scholar

Qiao J, Tan Y, Liu H, Yang B, Zhang Q, Liu Q, Sun W, Li Z, Wang Q, Feng W, et al: Histone H3K18 and ezrin lactylation promote renal dysfunction in sepsis-associated acute kidney injury. Adv Sci (Weinh). 11:e23072162024. View Article : Google Scholar : PubMed/NCBI

Catrina SB and Zheng X: Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia. 64:709–716. 2021. View Article : Google Scholar : PubMed/NCBI

Yamazaki T, Mimura I, Tanaka T and Nangaku M: Treatment of diabetic kidney disease: Current and future. Diabetes Metab J. 45:11–26. 2021. View Article : Google Scholar : PubMed/NCBI

Feng X, Wang S, Sun Z, Dong H, Yu H, Huang M and Gao X: Ferroptosis enhanced diabetic renal tubular injury via HIF-1α/HO-1 pathway in db/db mice. Front Endocrinol (Lausanne). 12:6263902021. View Article : Google Scholar

Mei S, Li L, Zhou X, Xue C, Livingston MJ, Wei Q, Dai B, Mao Z, Mei C and Dong Z: Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor-1. FASEB J. 36:e224772022. View Article : Google Scholar : PubMed/NCBI

Dou L and Jourde-Chiche N: Endothelial toxicity of high glucose and its by-Products in diabetic kidney disease. Toxins (Basel). 11:5782019. View Article : Google Scholar : PubMed/NCBI

Fu ZJ, Wang ZY, Xu L, Chen XH, Li XX, Liao WT, Ma HK, Jiang MD, Xu TT, Xu J, et al: HIF-1alpha-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury. Redox Biol. 36:1016712020. View Article : Google Scholar

Sulkshane P, Ram J, Thakur A, Reis N, Kleifeld O and Glickman MH: Ubiquitination and receptor-mediated mitophagy converge to eliminate oxidation-damaged mitochondria during hypoxia. Redox Biol. 45:1020472021. View Article : Google Scholar : PubMed/NCBI

Liu C, Yang M, Li L, Luo S, Yang J, Li C, Liu H and Sun L: A Glimpse of inflammation and Anti-inflammation therapy in diabetic kidney disease. Front Physiol. 13:9095692022. View Article : Google Scholar : PubMed/NCBI

Luo Y, Yang Z, Yu Y and Zhang P: HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. Int J Biol Macromol. 222:2225–2243. 2022. View Article : Google Scholar : PubMed/NCBI

Yi W, Clark PM, Mason DE, Keenan MC, Hill C, Goddard WA III, Peters EC, Driggers EM and Hsieh-Wilson LC: Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science. 337:975–980. 2012. View Article : Google Scholar : PubMed/NCBI

Fernandes PM, Kinkead J, McNae I, Michels PAM and Walkinshaw MD: Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches. Biochem J. 477:4425–4441. 2020. View Article : Google Scholar : PubMed/NCBI

Lang L, Chemmalakuzhy R, Shay C and Teng Y: PFKP signaling at a glance: An emerging mediator of cancer cell metabolism. Adv Exp Med Biol. 1134:243–258. 2019. View Article : Google Scholar : PubMed/NCBI

Meira DD, Marinho-Carvalho MM, Teixeira CA, Veiga VF, Da Poian AT, Holandino C, de Freitas MS and Sola-Penna M: Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes. Mol Genet Metab. 84:354–362. 2005. View Article : Google Scholar : PubMed/NCBI

Zhang Z, Liang W, Luo Q, Hu H, Yang K, Hu J, Chen Z, Zhu J, Feng J, Zhu Z, et al: PFKP activation ameliorates foot process fusion in podocytes in diabetic kidney disease. Front Endocrinol (Lausanne). 12:7970252021. View Article : Google Scholar

Cheng Z, Huang H, Li M and Chen Y: Proteomic analysis identifies PFKP lactylation in SW480 colon cancer cells. iScience. 27:1086452024. View Article : Google Scholar

Pritchett J, Athwal V, Roberts N, Hanley NA and Hanley KP: Understanding the role of SOX9 in acquired diseases: Lessons from development. Trends Mol Med. 17:166–174. 2011. View Article : Google Scholar : PubMed/NCBI

Symon A and Harley V: SOX9: A genomic view of tissue specific expression and action. Int J Biochem Cell Biol. 87:18–22. 2017. View Article : Google Scholar : PubMed/NCBI

Lefebvre V and Dvir-Ginzberg M: SOX9 and the many facets of its regulation in the chondrocyte lineage. Connect Tissue Res. 58:2–14. 2017. View Article : Google Scholar

Grimm D, Bauer J, Wise P, Krüger M, Simonsen U, Wehland M, Infanger M and Corydon TJ: The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol. 67:122–153. 2020. View Article : Google Scholar

Kishi S, Abe H, Akiyama H, Tominaga T, Murakami T, Mima A, Nagai K, Kishi F, Matsuura M, Matsubara T, et al: SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy. J Biol Chem. 286:32162–32169. 2011. View Article : Google Scholar : PubMed/NCBI

Li H, Cai H, Deng J, Tu X, Sun Y, Huang Z, Ding Z, Dong L, Chen J, Zang Y and Zhang J: TGF-β-mediated upregulation of Sox9 in fibroblast promotes renal fibrosis. Biochim Biophys Acta Mol Basis Dis. 1864:520–532. 2018. View Article : Google Scholar

Yan F, Teng Y, Li X, Zhong Y, Li C, Yan F and He X: Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer Biol Ther. 25:23041612024. View Article : Google Scholar : PubMed/NCBI

Baubec T, Ivanek R, Lienert F and Schubeler D: Methylation-dependent and -independent genomic targeting principles of the MBD protein family. Cell. 153:480–492. 2013. View Article : Google Scholar : PubMed/NCBI

Clouaire T and Stancheva I: Methyl-CpG binding proteins: Specialized transcriptional repressors or structural components of chromatin? Cell Mol Life Sci. 65:1509–1522. 2008. View Article : Google Scholar : PubMed/NCBI

Cheng TL, Wang Z, Liao Q, Zhu Y, Zhou WH, Xu W and Qiu Z: MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex. Dev Cell. 28:547–560. 2014. View Article : Google Scholar : PubMed/NCBI

Partscht P, Simon A, Chen NP, Erhardt S and Schiebel E: The HIPK2/CDC14B-MeCP2 axis enhances the spindle assembly checkpoint block by promoting cyclin B translation. Sci Adv. 9:eadd69822023. View Article : Google Scholar : PubMed/NCBI

Oh HJ, Kato M, Deshpande S, Zhang E, Das S, Lanting L, Wang M and Natarajan R: Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy. Sci Rep. 6:387892016. View Article : Google Scholar : PubMed/NCBI

Wang Y, Chen L, Zhang M, Li X, Yang X, Huang T, Ban Y, Li Y, Li Q, Zheng Y, et al: Exercise-induced endothelial Mecp2 lactylation suppresses atherosclerosis via the Ereg/MAPK signalling pathway. Atherosclerosis. 375:45–58. 2023. View Article : Google Scholar : PubMed/NCBI

Ingham RJ, Gish G and Pawson T: The Nedd4 family of E3 ubiquitin ligases: Functional diversity within a common modular architecture. Oncogene. 23:1972–1984. 2004. View Article : Google Scholar : PubMed/NCBI

Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo C, et al: NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell. 128:129–139. 2007. View Article : Google Scholar : PubMed/NCBI

Fujio Y, Nguyen T, Wencker D, Kitsis RN and Walsh K: Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 101:660–667. 2000. View Article : Google Scholar : PubMed/NCBI

Murdaca J, Treins C, Monthouel-Kartmann MN, Pontier-Bres R, Kumar S, Van Obberghen E and Giorgetti-Peraldi S: Grb10 prevents Nedd4-mediated vascular endothelial growth factor receptor-2 degradation. J Biol Chem. 279:26754–26761. 2004. View Article : Google Scholar : PubMed/NCBI

Han F, Wu S, Dong Y, Liu Y, Sun B and Chen L: Aberrant expression of NEDD4L disrupts mitochondrial homeostasis by downregulating CaMKKβ in diabetic kidney disease. J Transl Med. 22:4652024. View Article : Google Scholar

Henshall TL, Manning JA, Alfassy OS, Goel P, Boase NA, Kawabe H and Kumar S: Deletion of Nedd4-2 results in progressive kidney disease in mice. Cell Death Differ. 24:2150–2160. 2017. View Article : Google Scholar : PubMed/NCBI

Al-Qusairi L, Basquin D, Roy A, Rajaram RD, Maillard MP, Subramanya AR and Staub O: Renal tubular Ubiquitin-Protein ligase NEDD4-2 is required for renal adaptation during long-term potassium depletion. J Am Soc Nephrol. 28:2431–2442. 2017. View Article : Google Scholar : PubMed/NCBI

Wu P, Su XT, Gao ZX, Zhang DD, Duan XP, Xiao Y, Staub O, Wang WH and Lin DH: Renal tubule Nedd4-2 deficiency stimulates Kir4.1/Kir5.1 and Thiazide-sensitive NaCl cotransporter in distal convoluted tubule. J Am Soc Nephrol. 31:1226–1242. 2020. View Article : Google Scholar : PubMed/NCBI

Li Q, Zhang F, Wang H, Tong Y, Fu Y, Wu K, Li J, Wang C, Wang Z, Jia Y, et al: NEDD4 lactylation promotes APAP induced liver injury through Caspase11 dependent non-canonical pyroptosis. Int J Biol Sci. 20:1413–1435. 2024. View Article : Google Scholar : PubMed/NCBI

Aksan I and Goding CR: Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo. Mol Cell Biol. 18:6930–6938. 1998. View Article : Google Scholar : PubMed/NCBI

Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, et al: TFEB links autophagy to lysosomal biogenesis. Science. 332:1429–1433. 2011. View Article : Google Scholar : PubMed/NCBI

Song JX, Sun YR, Peluso I, Zeng Y, Yu X, Lu JH, Xu Z, Wang MZ, Liu LF, Huang YY, et al: A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition. Autophagy. 12:1372–1389. 2016. View Article : Google Scholar : PubMed/NCBI

Kim SH, Kim G, Han DH, Lee M, Kim I, Kim B, Kim KH, Song YM, Yoo JE, Wang HJ, et al: Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Autophagy. 13:1767–1781. 2017. View Article : Google Scholar : PubMed/NCBI

Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, et al: A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31:1095–1108. 2012. View Article : Google Scholar : PubMed/NCBI

Yuan Y, Li L, Zhu L, Liu F, Tang X, Liao G, Liu J, Cheng J, Chen Y and Lu Y: Mesenchymal stem cells elicit macrophages into M2 phenotype via improving transcription factor EB-mediated autophagy to alleviate diabetic nephropathy. Stem Cells. 38:639–652. 2020. View Article : Google Scholar : PubMed/NCBI

Rask-Madsen C and King GL: Diabetes: Podocytes lose their footing. Nature. 468:42–44. 2010. View Article : Google Scholar : PubMed/NCBI

Zhao X, Chen Y, Tan X, Zhang L, Zhang H, Li Z, Liu S, Li R, Lin T, Liao R, et al: Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB. J Pathol. 245:235–248. 2018. View Article : Google Scholar : PubMed/NCBI

Jacinto E: TFEBulous control of traffic by mTOR. EMBO J. 30:3215–3216. 2011. View Article : Google Scholar : PubMed/NCBI

Li T, Yin L, Kang X, Xue W, Wang N, Zhang J, Yuan P, Lin L and Li Y: TFEB acetylation promotes lysosome biogenesis and ameliorates Alzheimer's disease-relevant phenotypes in mice. J Biol Chem. 298:1026492022. View Article : Google Scholar : PubMed/NCBI

Martina JA and Puertollano R: Protein phosphatase 2A stimulates activation of TFEB and TFE3 transcription factors in response to oxidative stress. J Biol Chem. 293:12525–12534. 2018. View Article : Google Scholar : PubMed/NCBI

Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O, Huynh T, Carissimo A, Palmer D, Klisch TJ, et al: TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol. 15:647–658. 2013. View Article : Google Scholar : PubMed/NCBI

Sha Y, Rao L, Settembre C, Ballabio A and Eissa NT: STUB1 regulates TFEB-induced autophagy-lysosome pathway. EMBO J. 36:2544–2552. 2017. View Article : Google Scholar : PubMed/NCBI

Huang Y, Luo G, Peng K, Song Y, Wang Y, Zhang H, Li J, Qiu X, Pu M, Liu X, et al: Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity. J Cell Biol. 223:e2023080992024. View Article : Google Scholar : PubMed/NCBI

Qu D, Jiang M, Huang D, Zhang H, Feng L, Chen Y, Zhu X, Wang S and Han J: Synergistic effects of the enhancements to mitochondrial ROS, p53 activation and apoptosis generated by aspartame and potassium sorbate in HepG2 cells. Molecules. 24:4572019. View Article : Google Scholar : PubMed/NCBI

Kruiswijk F, Labuschagne CF and Vousden KH: p53 in survival, death and metabolic health: A lifeguard with a licence to kill. Nat Rev Mol Cell Biol. 16:393–405. 2015. View Article : Google Scholar : PubMed/NCBI

Saldana-Meyer R and Recillas-Targa F: Transcriptional and epigenetic regulation of the p53 tumor suppressor gene. Epigenetics. 6:1068–1077. 2011. View Article : Google Scholar : PubMed/NCBI

Mulay SR, Thomasova D, Ryu M and Anders HJ: MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice. Kidney Int. 81:1199–1211. 2012. View Article : Google Scholar : PubMed/NCBI

Peng J, Li X, Zhang D, Chen JK, Su Y, Smith SB and Dong Z: Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injury. Kidney Int. 87:137–150. 2015. View Article : Google Scholar :

Yang R, Xu X, Li H, Chen J, Xiang X, Dong Z and Zhang D: p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO. Sci Rep. 7:434092017. View Article : Google Scholar : PubMed/NCBI

Brezniceanu ML, Liu F, Wei CC, Chénier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR and Chan JS: Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes. 57:451–459. 2008. View Article : Google Scholar

Brezniceanu ML, Liu F, Wei CC, Tran S, Sachetelli S, Zhang SL, Guo DF, Filep JG, Ingelfinger JR and Chan JS: Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int. 71:912–923. 2007. View Article : Google Scholar : PubMed/NCBI

Qi R, Wang J, Jiang Y, Qiu Y, Xu M, Rong R and Zhu T: Snai1-induced partial epithelial-mesenchymal transition orchestrates p53-p21-mediated G2/M arrest in the progression of renal fibrosis via NF-κB-mediated inflammation. Cell Death Dis. 12:442021. View Article : Google Scholar

Sutton TA, Hato T, Mai E, Yoshimoto M, Kuehl S, Anderson M, Mang H, Plotkin Z, Chan RJ and Dagher PC: p53 is renoprotective after ischemic kidney injury by reducing inflammation. J Am Soc Nephrol. 24:113–124. 2013. View Article : Google Scholar :

Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B and Zhou F: Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 187:2375–2392.e33. 2024. View Article : Google Scholar : PubMed/NCBI

Russo GL, Russo M and Ungaro P: AMP-activated protein kinase: A target for old drugs against diabetes and cancer. Biochem Pharmacol. 86:339–350. 2013. View Article : Google Scholar : PubMed/NCBI

Momcilovic M, Hong SP and Carlson M: Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem. 281:25336–25343. 2006. View Article : Google Scholar : PubMed/NCBI

Rogacka D, Piwkowska A, Audzeyenka I, Angielski S and Jankowski M: Involvement of the AMPK-PTEN pathway in insulin resistance induced by high glucose in cultured rat podocytes. Int J Biochem Cell Biol. 51:120–130. 2014. View Article : Google Scholar : PubMed/NCBI

Jørgensen SB, Viollet B, Andreelli F, Frøsig C, Birk JB, Schjerling P, Vaulont S, Richter EA and Wojtaszewski JF: Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem. 279:1070–1079. 2004. View Article : Google Scholar

Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P and Auwerx J: AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 458:1056–1060. 2009. View Article : Google Scholar : PubMed/NCBI

Godel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, Debreczeni-Mór A, Lindenmeyer MT, Rastaldi MP and Hartleben G: Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 121:2197–2209. 2011. View Article : Google Scholar : PubMed/NCBI

Guo H, Wang Y, Zhang X, Zang Y, Zhang Y, Wang L, Wang H, Wang Y, Cao A and Peng W: Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy. Sci Rep. 7:68522017. View Article : Google Scholar

Zhang Y, Huang Z, Han W, Wu J, Li S, Qin T, Zhang C, Shi M, Han S, Gao B, et al: Glutamine suppresses senescence and promotes autophagy through glycolysis inhibition-mediated AMPKα lactylation in intervertebral disc degeneration. Commun Biol. 7:3252024. View Article : Google Scholar

Hou X, Hong Z, Zeng H, Zhang C, Zhang P, Ma D and Han Z: Lactylation in cancer biology: Unlocking new avenues for research and therapy. Cancer Commun (Lond). 45:1367–1406. 2025. View Article : Google Scholar : PubMed/NCBI

Wu Z, Peng Y, Chen W, Xia F, Song T and Ke Q: Lactylation-driven transcriptional activation of FBXO33 promotes gallbladder cancer metastasis by regulating p53 polyubiquitination. Cell Death Dis. 16:1442025. View Article : Google Scholar : PubMed/NCBI

Feng L, Feng YY, Ren Q, Fu P and Ma L: Mesangial cells in diabetic kidney disease: From mechanisms to therapeutic implications. Int J Biol Sci. 21:4762–4781. 2025. View Article : Google Scholar : PubMed/NCBI

Zhang S, Luo M, Lu Z and Shi Q: Lactate and lactylation in sepsis-associated acute kidney injury: Clinical evidence from the MIMIC-IV database and mechanistic insights. Front Med (Lausanne). 12:17081452025. View Article : Google Scholar : PubMed/NCBI

Zhang D, Liang C, Wu C, Hawanga M, Wan S, Xu L, Zhang X, Liu Y, Hu F, Wang M, et al: Nonhistone lactylation: A hub for tumour metabolic reprogramming and epigenetic regulation. J Transl Med. 23:9012025. View Article : Google Scholar : PubMed/NCBI

Kung CP and Murphy ME: The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol. 231:R61–R75. 2016. View Article : Google Scholar : PubMed/NCBI

Sun T, Liu B, Li Y, Wu J, Cao Y, Yang S, Tan H, Cai L, Zhang S, Qi X, et al: Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation. J Exp Clin Cancer Res. 42:2532023. View Article : Google Scholar : PubMed/NCBI

Marlier JF, Cleland WW and Zeczycki TN: Oxamate is an alternative substrate for pyruvate carboxylase from Rhizobium etli. Biochemistry. 52:2888–2894. 2013. View Article : Google Scholar : PubMed/NCBI

Altinoz MA and Ozpinar A: Oxamate targeting aggressive cancers with special emphasis to brain tumors. Biomed Pharmacother. 147:1126862022. View Article : Google Scholar : PubMed/NCBI

Ye W, Zheng Y, Zhang S, Yan L, Cheng H and Wu M: Oxamate improves glycemic control and insulin sensitivity via inhibition of tissue lactate production in db/db Mice. PLoS One. 11:e01503032016. View Article : Google Scholar : PubMed/NCBI

Friberg A, Rehwinkel H, Nguyen D, Pütter V, Quanz M, Weiske J, Eberspächer U, Heisler I and Langer G: Structural evidence for isoform-selective allosteric inhibition of lactate dehydrogenase A. ACS Omega. 5:13034–13041. 2020. View Article : Google Scholar : PubMed/NCBI

Hollenberg AM, Smith CO, Shum LC, Awad H and Eliseev RA: Lactate dehydrogenase inhibition with oxamate exerts bone anabolic effect. J Bone Miner Res. 35:2432–2443. 2020. View Article : Google Scholar : PubMed/NCBI

Qiao T, Xiong Y, Feng Y, Guo W, Zhou Y, Zhao J, Jiang T, Shi C and Han Y: Inhibition of LDH-A by oxamate enhances the efficacy of Anti-PD-1 treatment in an NSCLC humanized mouse model. Front Oncol. 11:6323642021. View Article : Google Scholar : PubMed/NCBI

Shibata S, Sogabe S, Miwa M, Fujimoto T, Takakura N, Naotsuka A, Kitamura S, Kawamoto T and Soga T: Identification of the first highly selective inhibitor of human lactate dehydrogenase B. Sci Rep. 11:213532021. View Article : Google Scholar : PubMed/NCBI

Rai G, Brimacombe KR, Mott BT, Urban DJ, Hu X, Yang SM, Lee TD, Cheff DM, Kouznetsova J, Benavides GA, et al: Discovery and optimization of potent, Cell-active pyrazole-based inhibitors of lactate dehydrogenase (LDH). J Med Chem. 60:9184–9204. 2017. View Article : Google Scholar : PubMed/NCBI

Han JH, Lee EJ, Park W, Ha KT and Chung HS: Natural compounds as lactate dehydrogenase inhibitors: Potential therapeutics for lactate dehydrogenase inhibitors-related diseases. Front Pharmacol. 14:12750002023. View Article : Google Scholar : PubMed/NCBI

El Hassouni B, Franczak M, Capula M, Vonk CM, Gomez VM, Smolenski RT, Granchi C, Peters GJ, Minutolo F and Giovannetti E: Lactate dehydrogenase A inhibition by small molecular entities: Steps in the right direction. Oncoscience. 7:76–80. 2020. View Article : Google Scholar : PubMed/NCBI

Hwang D, Kim T, Kyun S, Jang I, Park HY, Kim SW, Han JS, So JM, Lee CH, Park J, et al: Oxamate suppresses whole-body energy metabolism at rest and during exercise in mice by inhibiting fat oxidation and altering lactate dynamics. Phys Act Nutr. 29:26–34. 2025. View Article : Google Scholar : PubMed/NCBI

Zhai X, Yang Y, Wan J, Zhu R and Wu Y: Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells. Oncol Rep. 30:2983–2991. 2013. View Article : Google Scholar : PubMed/NCBI

Ouyang J, Wang H and Huang J: The role of lactate in cardiovascular diseases. Cell Commun Signal. 21:3172023. View Article : Google Scholar : PubMed/NCBI

Cui D and Morris ME: The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): Characterization of SMCT-mediated uptake and inhibition. Drug Metab Dispos. 37:1404–1410. 2009. View Article : Google Scholar : PubMed/NCBI

Emoto A, Ushigome F, Koyabu N, Kajiya H, Okabe K, Satoh S, Tsukimori K, Nakano H, Ohtani H and Sawada Yl: H(+)-linked transport of salicylic acid, an NSAID, in the human trophoblast cell line BeWo. Am J Physiol Cell Physiol. 282:C1064–C1075. 2002. View Article : Google Scholar : PubMed/NCBI

Richard AN, Natalie B, Helen B, Sikka A, Thomas H, Phillips N, Nakjang S, Miwa S, Crossland R, Rand V, et al: Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma. Haematologica. 102:1247–1257. 2017. View Article : Google Scholar

Bola BM, Chadwick AL, Michopoulos F, Blount KG, Telfer BA, Williams KJ, Smith PD, Critchlow SE and Stratford IJ: Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport. Mol Cancer Ther. 13:2805–2816. 2014. View Article : Google Scholar : PubMed/NCBI

Beloueche-Babari M, Wantuch S, Casals Galobart T, Koniordou M, Parkes HG, Arunan V, Chung YL, Eykyn TR, Smith PD and Leach MO: MCT1 Inhibitor AZD3965 increases mitochondrial metabolism, facilitating combination therapy and noninvasive magnetic resonance spectroscopy. Cancer Res. 77:5913–5924. 2017. View Article : Google Scholar : PubMed/NCBI

Xu Z and Wang X, Cheng H, Li J, Zhang X and Wang X: The role of MCT1 in tumor progression and targeted therapy: A comprehensive review. Front Immunol. 16:16104662025. View Article : Google Scholar : PubMed/NCBI

Halford SER, Jones P, Wedge S, Hirschberg S, Katugampola S, Veal G, Payne G and Plummer ER: A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours. J Clin Oncol. 35:2516. 2017. View Article : Google Scholar

Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, Dragoni I, Heinzmann K, Potter S, Salisbury BM, et al: A Phase I Dose-escalation Study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer. Clin Cancer Res. 29:1429–1439. 2023. View Article : Google Scholar : PubMed/NCBI

Huang T, Feng Q, Wang Z, Li W, Sun Z, Wilhelm J, Huang G, Vo T, Sumer BD and Gao J: Tumor-Targeted inhibition of monocarboxylate transporter 1 improves T-cell immunotherapy of solid tumors. Adv Healthc Mater. 10:20005492021. View Article : Google Scholar

Wu G, Pan Y, Chen M, Liu Z, Li C, Sheng Y, Li H, Shen M and Liu H: Lactylation drives hCG-triggered luteinization in hypoxic granulosa cells. Int J Biol Macromol. 280:1355802024. View Article : Google Scholar : PubMed/NCBI

Leng S, Huang W, Chen Y, Yang Y, Feng D, Liu W, Gao T, Ren Y, Huo M, Zhang J, et al: SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. Cell Death Differ. 28:3329–3343. 2021. View Article : Google Scholar : PubMed/NCBI

Peng J, Li J, Huang J, Xu P, Huang H, Liu Y, Yu L, Yang Y, Zhou B, Jiang H, et al: p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization. Theranostics. 9:8344–8361. 2019. View Article : Google Scholar : PubMed/NCBI

Jaschke NP, Breining D, Hofmann M, Pählig S, Baschant U, Oertel R, Traikov S, Grinenko T, Saettini F, Biondi A, et al: Small-molecule CBP/p300 histone acetyltransferase inhibition mobilizes leukocytes from the bone marrow via the endocrine stress response. Immunity. 57:364–378.e9. 2024. View Article : Google Scholar : PubMed/NCBI

Ji C, Xu W, Ding H, Chen Z, Shi C, Han J, Yu L, Qiao N, Zhang Y, Cao X, et al: The p300 inhibitor A-485 exerts antitumor activity in growth hormone pituitary adenoma. J Clin Endocrinol Metab. 107:e2291–e2300. 2022. View Article : Google Scholar : PubMed/NCBI

Ansari MSZ, Stagni V, Iuzzolino A, Rotili D, Mai A, Del Bufalo D, Lavia P, Degrassi F and Trisciuoglio D: Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells. Cancer Gene Therapy. 30:124–136. 2023. View Article : Google Scholar :

Dai SK, Liu PP, Li X, Jiao LF, Teng ZQ and Liu CM: Dynamic profiling and functional interpretation of histone lysine crotonylation and lactylation during neural development. Development. 149:dev2000492022. View Article : Google Scholar : PubMed/NCBI

Bursch KL, Goetz CJ and Smith BC: Current trends in sirtuin activator and inhibitor development. Molecules. 29:11852024. View Article : Google Scholar : PubMed/NCBI

Yu S, Li Y, Lu X, Han Z, Li C, Yuan X and Guo D: The regulatory role of miRNA and lncRNA on autophagy in diabetic nephropathy. Cell Signal. 118:1111442024. View Article : Google Scholar : PubMed/NCBI

Zhang Y and Zhang X: Virus-induced histone lactylation promotes virus infection in crustacean. Adv Sci (Weinh). 11:e24010172024. View Article : Google Scholar : PubMed/NCBI

Liu L, Chen Y, Li X, Wang J and Yang L: Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy. Biomed Pharmacother. 175:1166722024. View Article : Google Scholar : PubMed/NCBI

van Son J, Oussaada SM, Şekercan A, Beudel M, Dongelmans DA, van Assen S, Eland IA, Moeniralam HS, Dormans TPJ, van Kalkeren CAJ, et al: Overweight and obesity are associated with acute kidney injury and acute respiratory distress syndrome, but not with increased mortality in hospitalized COVID-19 patients: A retrospective cohort study. Front Endocrinol (Lausanne). 12:7477322021. View Article : Google Scholar :

Schiller M, Solger K, Leipold S, Kerl HU and Kick W: Diabetes-associated nephropathy and obesity influence COVID-19 outcome in type 2 diabetes patients. J Community Hosp Intern Med Perspect. 11:590–596. 2021. View Article : Google Scholar : PubMed/NCBI

Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O'Rahilly S, Aveyard P and Jebb SA: Associations between body-mass index and COVID-19 severity in 6•9 million people in England: A prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 9:350–359. 2021. View Article : Google Scholar : PubMed/NCBI

Sörling A, Nordberg P, Hofmann R, Häbel H and Svensson P: Association between CKD, obesity, cardiometabolic risk factors, and severe COVID-19 outcomes. Kidney Int Rep. 8:775–784. 2023. View Article : Google Scholar : PubMed/NCBI

Martín-Del-Campo F, Ruvalcaba-Contreras N, Velázquez-Vidaurri AL, Cueto-Manzano AM, Rojas-Campos E, Cortés-Sanabria L, Espinel-Bermúdez MC, Hernández-González SO, Nava-Zavala AH, Fuentes-Orozco C, et al: Morbid obesity is associated with mortality and acute kidney injury in hospitalized patients with COVID-19. Clin Nutr ESPEN. 45:200–205. 2021. View Article : Google Scholar : PubMed/NCBI

Al-Sabah S, Al-Haddad M, Al-Youha S, Jamal M and Almazeedi S: COVID-19: Impact of obesity and diabetes on disease severity. Clin Obes. 10:e124142020. View Article : Google Scholar : PubMed/NCBI

Li LN, Li WW, Xiao LS and Lai WN: Lactylation signature identifies liver fibrosis phenotypes and traces fibrotic progression to hepatocellular carcinoma. Front Immunol. 15:14333932024. View Article : Google Scholar : PubMed/NCBI

Wang P, Xie D, Xiao T, Cheng C, Wang D, Sun J, Wu M, Yang Y, Zhang A and Liu Q: H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP. J Hazard Mater. 461:1325822024. View Article : Google Scholar

Liang H, Xu L and Yang Y: Lactate and lactylation: Novel perspectives on fibrosis pathogenesis and therapeutic directions. J Transl Med. 23:7052025. View Article : Google Scholar : PubMed/NCBI

Nechipurenko YD, Semyonov DA, Lavrinenko IA, Lagutkin DA, Generalov EA, Zaitceva AY, Matveeva OV and Yegorov YE: The role of acidosis in the pathogenesis of severe forms of COVID-19. Biology (Basel). 10:8522021.PubMed/NCBI

Wang X, Li Y, Qiang G, Wang K, Dai J, McCann M, Munoz MD, Gil V, Yu Y, Li S, et al: Secreted EMC10 is upregulated in human obesity and its neutralizing antibody prevents diet-induced obesity in mice. Nat Commun. 13:73232022. View Article : Google Scholar : PubMed/NCBI

Gupta GS: The lactate and the lactate dehydrogenase in inflammatory diseases and major risk factors in COVID-19 patients. Inflammation. 45:2091–2123. 2022. View Article : Google Scholar : PubMed/NCBI

Bao C, Ma Q, Ying X, Wang F, Hou Y, Wang D, Zhu L, Huang J and He C: Histone lactylation in macrophage biology and disease: From plasticity regulation to therapeutic implications. eBioMedicine. 111:1055022025. View Article : Google Scholar :

Li C, Fu C, Zhou W, Li H, Liu Z, Wu G, He T, Shen M and Liu H: Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition. Cell Commun Signal. 23:3642025. View Article : Google Scholar

Thyrsted J, Storgaard J, Blay-Cadanet J, Heinz A, Thielke AL, Crotta S, de Paoli F, Olagnier D, Wack A, Hiller K, et al: Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium. iScience. 24:1033002021. View Article : Google Scholar : PubMed/NCBI

Wu J, Li Y, Yang Y, Chen R, Wang H, Xie K, Lan J, Guo M, Zhang Y and Li X: Wogonoside inhibits fibroblast activation and pulmonary fibrosis by dual regulation of Snail1 lactylation and PGC1α/PINK1-mediated mitophagy. Phytomedicine. 147:1572402025. View Article : Google Scholar